Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

George A. Jacoby, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI057576 (HOOPER, DAVID C) Jan 1, 2004 - Jun 30, 2019
    Plasmid-mediated Quinolone Resistance
    Role: Co-Principal Investigator
  2. R01AI043312 (JACOBY, GEORGE A) Mar 15, 1999 - Mar 31, 2009
    Plasmid-Mediated Quinolone Resistance
    Role: Principal Investigator
  3. R01AI020415 (JACOBY, GEORGE A) Sep 30, 1984 - Aug 31, 1991
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Monárrez R, Wang Y, Fu Y, Liao CH, Okumura R, Braun MR, Jacoby GA, Hooper DC. Genes and Proteins Involved in qnrS1 Induction. Antimicrob Agents Chemother. 2018 Sep; 62(9). PMID: 29914953.
    View in: PubMed
  2. Vinué L, Hooper DC, Jacoby GA. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli. Int J Antimicrob Agents. 2018 Mar; 51(3):479-483. PMID: 29360506.
    View in: PubMed
  3. Jacoby GA. Study of Plasmid-Mediated Quinolone Resistance in Bacteria. Methods Mol Biol. 2018; 1703:317-325. PMID: 29177751.
    View in: PubMed
  4. Jacoby GA, Bush K. Reply to Furlan et al., "Importance of Sequencing To Determine Functional blaTEM Variants". Antimicrob Agents Chemother. 2017 05; 61(5). PMID: 28438798.
    View in: PubMed
  5. Jacoby GA, Bush K. The Curious Case of TEM-116. Antimicrob Agents Chemother. 2016 11; 60(11):7000. PMID: 28045664.
    View in: PubMed
  6. Hooper DC, Jacoby GA. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med. 2016 Sep 01; 6(9). PMID: 27449972.
    View in: PubMed
  7. Jacoby GA, Bonomo RA, Bradford PA, Bush K, Doi Y, Feldgarden M, Haft D, Klimke W, Nordmann P, Palzkill T, Poirel L, Prasad A, Rossolini GM, Walsh T. Comment on: Resistance gene naming and numbering: is it a new gene or not? J Antimicrob Chemother. 2016 09; 71(9):2677-8. PMID: 27261266.
    View in: PubMed
  8. Vinué L, Corcoran MA, Hooper DC, Jacoby GA. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1. Antimicrob Agents Chemother. 2015 Dec 28; 60(3):1537-45. PMID: 26711751; PMCID: PMC4776012.
  9. Chen C, Villet R, Jacoby GA, Hooper DC. Functions of a GyrBA fusion protein and its interaction with QnrB and quinolones. Antimicrob Agents Chemother. 2015 Nov; 59(11):7124-7. PMID: 26324265; PMCID: PMC4604398.
  10. Jacoby GA, Corcoran MA, Hooper DC. Protective effect of Qnr on agents other than quinolones that target DNA gyrase. Antimicrob Agents Chemother. 2015 Nov; 59(11):6689-95. PMID: 26239981; PMCID: PMC4604369.
  11. Hooper DC, Jacoby GA. Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci. 2015 Sep; 1354:12-31. PMID: 26190223; PMCID: PMC4626314.
  12. Kim ES, Chen C, Braun M, Kim HY, Okumura R, Wang Y, Jacoby GA, Hooper DC. Interactions between QnrB, QnrB mutants, and DNA gyrase. Antimicrob Agents Chemother. 2015 Sep; 59(9):5413-9. PMID: 26100716; PMCID: PMC4538543.
  13. Kwak YG, Jacoby GA, Hooper DC. Effect of Qnr on Plasmid Gyrase Toxins CcdB and ParE. Antimicrob Agents Chemother. 2015 Aug; 59(8):5078-9. PMID: 26055367; PMCID: PMC4505230.
  14. Li H, Estabrook M, Jacoby GA, Nichols WW, Testa RT, Bush K. In vitro susceptibility of characterized ß-lactamase-producing strains tested with avibactam combinations. Antimicrob Agents Chemother. 2015 Mar; 59(3):1789-93. PMID: 25534728; PMCID: PMC4325778.
  15. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014 Oct; 2(5). PMID: 25584197.
    View in: PubMed
  16. Rice LB, Eliopoulos GM, Jacoby GA. In memoriam: Robert C. Moellering, Jr. Antimicrob Agents Chemother. 2014 Jul; 58(7):3583-4. PMID: 24798286; PMCID: PMC4068561.
  17. Tavío MM, Jacoby GA, Hooper DC. QnrS1 structure-activity relationships. J Antimicrob Chemother. 2014 Aug; 69(8):2102-9. PMID: 24729602; PMCID: PMC4100707.
  18. Jacoby GA, Corcoran MA, Mills DM, Griffin CM, Hooper DC. Mutational analysis of quinolone resistance protein QnrB1. Antimicrob Agents Chemother. 2013 Nov; 57(11):5733-6. PMID: 23979738; PMCID: PMC3811324.
  19. Liao CH, Hsueh PR, Jacoby GA, Hooper DC. Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2013 Dec; 68(12):2907-14. PMID: 23956373; PMCID: PMC3820109.
  20. Kwak YG, Jacoby GA, Hooper DC. Induction of plasmid-carried qnrS1 in Escherichia coli by naturally occurring quinolones and quorum-sensing signal molecules. Antimicrob Agents Chemother. 2013 Aug; 57(8):4031-4. PMID: 23689721; PMCID: PMC3719764.
  21. Jacoby GA, Hooper DC. Phylogenetic analysis of chromosomally determined qnr and related proteins. Antimicrob Agents Chemother. 2013 Apr; 57(4):1930-4. PMID: 23318805; PMCID: PMC3623327.
  22. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI. Tackling antibiotic resistance. Nat Rev Microbiol. 2011 11 02; 9(12):894-6. PMID: 22048738.
    View in: PubMed
  23. Okumura R, Liao CH, Gavin M, Jacoby GA, Hooper DC. Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob Agents Chemother. 2011 Dec; 55(12):5942-5. PMID: 21930884; PMCID: PMC3232789.
  24. Jacoby GA, Griffin CM, Hooper DC. Citrobacter spp. as a source of qnrB Alleles. Antimicrob Agents Chemother. 2011 Nov; 55(11):4979-84. PMID: 21844311; PMCID: PMC3195048.
  25. Vetting MW, Hegde SS, Wang M, Jacoby GA, Hooper DC, Blanchard JS. Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem. 2011 Jul 15; 286(28):25265-73. PMID: 21597116; PMCID: PMC3137097.
  26. Kim HB, Park CH, Gavin M, Jacoby GA, Hooper DC. Cold shock induces qnrA expression in Shewanella algae. Antimicrob Agents Chemother. 2011 Jan; 55(1):414-6. PMID: 21078945; PMCID: PMC3019661.
  27. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother. 2010 Nov; 54(11):4643-7. PMID: 20733041; PMCID: PMC2976141.
  28. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010 Mar; 54(3):969-76. PMID: 19995920; PMCID: PMC2825993.
  29. Kim HB, Wang M, Ahmed S, Park CH, LaRocque RC, Faruque AS, Salam MA, Khan WA, Qadri F, Calderwood SB, Jacoby GA, Hooper DC. Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother. 2010 Feb; 54(2):799-803. PMID: 19949057; PMCID: PMC2812163.
  30. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009 Oct; 22(4):664-89. PMID: 19822894; PMCID: PMC2772364.
  31. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother. 2009 Aug; 53(8):3582-4. PMID: 19528276; PMCID: PMC2715617.
  32. Bush K, Jacoby GA, Amicosante G, Bonomo RA, Bradford P, Cornaglia G, Garau J, Giamarellou H, Jarlier V, Martinez-Martinez L, Miriagou V, Palzkill T, Pascual A, Rodriguez-Baño J, Rossolini GM, Sougakoff W, Vatopoulos A. Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother. 2009 Jul; 64(1):212-3; author reply 213-5. PMID: 19318363.
    View in: PubMed
  33. Jacoby GA, Gacharna N, Black TA, Miller GH, Hooper DC. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother. 2009 Apr; 53(4):1665-6. PMID: 19164145; PMCID: PMC2663075.
  34. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009 Jan; 22(1):161-82, Table of Contents. PMID: 19136439; PMCID: PMC2620637.
  35. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009 Feb; 53(2):639-45. PMID: 19064896; PMCID: PMC2630623.
  36. Wang M, Jacoby GA, Mills DM, Hooper DC. SOS regulation of qnrB expression. Antimicrob Agents Chemother. 2009 Feb; 53(2):821-3. PMID: 19029320; PMCID: PMC2630627.
  37. Vetting MW, Park CH, Hegde SS, Jacoby GA, Hooper DC, Blanchard JS. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant. Biochemistry. 2008 Sep 16; 47(37):9825-35. PMID: 18710261; PMCID: PMC2855648.
  38. Jacoby G, Cattoir V, Hooper D, Martínez-Martínez L, Nordmann P, Pascual A, Poirel L, Wang M. qnr Gene nomenclature. Antimicrob Agents Chemother. 2008 Jul; 52(7):2297-9. PMID: 18426894; PMCID: PMC2443900.
  39. Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, Medalla F, Jacoby GA, Barrett TJ. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis. 2007 Nov; 13(11):1681-8. PMID: 18217551; PMCID: PMC3375806.
  40. Shara MM, Martin CD, Seibert M, Rich RM, Salim S, Reitzel D, Schiminovich D, Deliyannis CP, Sarrazine AR, Kulkarni SR, Ofek EO, Brosch N, Lépine S, Zurek D, De Marco O, Jacoby G. An ancient nova shell around the dwarf nova Z Camelopardalis. Nature. 2007 Mar 08; 446(7132):159-62. PMID: 17344847.
    View in: PubMed
  41. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006 Oct; 6(10):629-40. PMID: 17008172.
    View in: PubMed
  42. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006 Nov; 50(11):3953-5. PMID: 16954321; PMCID: PMC1635235.
  43. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006 Aug; 50(8):2872-4. PMID: 16870791; PMCID: PMC1538681.
  44. Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, Barrett TJ, Medalla F, Chiller TM, Hooper DC. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis. 2006 Aug 01; 43(3):297-304. PMID: 16804843.
    View in: PubMed
  45. Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol. 2006 Jun; 44(6):1971-6. PMID: 16757586; PMCID: PMC1489443.
  46. Jacoby GA. Beta-lactamase nomenclature. Antimicrob Agents Chemother. 2006 Apr; 50(4):1123-9. PMID: 16569819; PMCID: PMC1426973.
  47. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, Hooper DC. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother. 2006 Apr; 50(4):1178-82. PMID: 16569827; PMCID: PMC1426915.
  48. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006 Jan; 12(1):83-8. PMID: 16369542.
    View in: PubMed
  49. Jacoby GA, Bush K. Beta-lactamase nomenclature. J Clin Microbiol. 2005 Dec; 43(12):6220. PMID: 16333139; PMCID: PMC1317221.
  50. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005 Jul 15; 41 Suppl 2:S120-6. PMID: 15942878.
    View in: PubMed
  51. Robicsek A, Sahm DF, Strahilevitz J, Jacoby GA, Hooper DC. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother. 2005 Jul; 49(7):3001-3. PMID: 15980384; PMCID: PMC1168650.
  52. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother. 2005 Jul; 49(7):3050-2. PMID: 15980397; PMCID: PMC1168640.
  53. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005 Jan 27; 352(4):380-91. PMID: 15673804.
    View in: PubMed
  54. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005 Jan; 49(1):118-25. PMID: 15616284; PMCID: PMC538914.
  55. Jacoby GA, Mills DM, Chow N. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004 Aug; 48(8):3203-6. PMID: 15273152; PMCID: PMC478483.
  56. Wang M, Sahm DF, Jacoby GA, Zhang Y, Hooper DC. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother. 2004 Apr; 48(4):1400-1. PMID: 15047552; PMCID: PMC375334.
  57. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004 Apr; 48(4):1295-9. PMID: 15047532; PMCID: PMC375335.
  58. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother. 2004 Feb; 48(2):533-7. PMID: 14742206; PMCID: PMC321551.
  59. Munoz LS, Jacoby G, Snydman DR. Extended-spectrum beta-lactamases. 2004.
  60. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003 Jul; 47(7):2242-8. PMID: 12821475; PMCID: PMC161834.
  61. Jacoby GA, Vacheva-Dobrevsky R. Epidemiology of extended-spectrum beta-lactamases in Sofia, Bulgaria. Eur J Clin Microbiol Infect Dis. 2003 Jun; 22(6):385-8. PMID: 12783281.
    View in: PubMed
  62. Martínez-Martínez L, Pascual A, García I, Tran J, Jacoby GA. Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother. 2003 Apr; 51(4):1037-9. PMID: 12654766.
    View in: PubMed
  63. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother. 2003 Feb; 47(2):559-62. PMID: 12543659; PMCID: PMC151764.
  64. Levison ME, Mailapur YV, Pradhan SK, Jacoby GA, Adams P, Emery CL, May PL, Pitsakis PG. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals. Clin Infect Dis. 2002 Dec 15; 35(12):1551-4. PMID: 12471576.
    View in: PubMed
  65. Arduino SM, Roy PH, Jacoby GA, Orman BE, Pineiro SA, Centron D. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother. 2002 Jul; 46(7):2303-6. PMID: 12069995; PMCID: PMC127297.
  66. Rasheed JK, Anderson GJ, Queenan AM, Biddle JW, Oliver A, Jacoby GA, Bush K, Tenover FC. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2002 Jun; 46(6):2000-3. PMID: 12019125; PMCID: PMC127224.
  67. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A. 2002 Apr 16; 99(8):5638-42. PMID: 11943863; PMCID: PMC122823.
  68. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother. 2002 Jan; 46(1):1-11. PMID: 11751104; PMCID: PMC126993.
  69. Pai H, Lee HJ, Choi EH, Kim J, Jacoby GA. Evolution of TEM-related extended-spectrum beta-lactamases in Korea. Antimicrob Agents Chemother. 2001 Dec; 45(12):3651-3. PMID: 11709362; PMCID: PMC90891.
  70. Pai H, Jacoby GA. Sequences of the NPS-1 and TLE-1 beta-lactamase genes. Antimicrob Agents Chemother. 2001 Oct; 45(10):2947-8. PMID: 11557499; PMCID: PMC90761.
  71. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol. 2001 Oct; 39(10):3747-9. PMID: 11574608; PMCID: PMC88424.
  72. Rasheed JK, Anderson GJ, Yigit H, Queenan AM, Doménech-Sánchez A, Swenson JM, Biddle JW, Ferraro MJ, Jacoby GA, Tenover FC. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob Agents Chemother. 2000 Sep; 44(9):2382-8. PMID: 10952583; PMCID: PMC90073.
  73. Jacoby GA, Tran J. Sequence of the MIR-1 beta-lactamase gene. Antimicrob Agents Chemother. 1999 Jul; 43(7):1759-60. PMID: 10390237; PMCID: PMC89358.
  74. Martínez-Martínez L, Pascual A, Hernández-Allés S, Alvarez-Díaz D, Suárez AI, Tran J, Benedí VJ, Jacoby GA. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother. 1999 Jul; 43(7):1669-73. PMID: 10390220; PMCID: PMC89341.
  75. Jacoby GA. History of antimicrobial agents and chemotherapy from 1972 to 1998 Antimicrob Agents Chemother. 1999 May; 43(5):999-1002. PMID: 10223906.
    View in: PubMed
  76. Jacoby GA. Mechanisms of antibacterial action and resistance. Root RK, Waldvogel F, Corey L, Stamm W, eds. Clinical infectious diseases: a practical approach. 1999; 209-15.
  77. Jacoby GA. Development of resistance in gram-negative pathogens. Extended-spectrum beta-lactamases. Emerging pathogens in infectious disease. A hospital practice special report. 1999; 14-21.
  78. Jacoby GA. Epidemiology of extended-spectrum beta-lactamases. Clin Infect Dis. 1998 Jul; 27(1):81-3. PMID: 9675457.
    View in: PubMed
  79. Martínez-Martínez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998 Mar 14; 351(9105):797-9. PMID: 9519952.
    View in: PubMed
  80. Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 1997 Dec; 11(4):875-87. PMID: 9421705.
    View in: PubMed
  81. Jacoby G, Han P, Tran J. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens. Antimicrob Agents Chemother. 1997 Aug; 41(8):1830-1. PMID: 9257772; PMCID: PMC164016.
  82. Bush K, Jacoby G. Nomenclature of TEM beta-lactamases. J Antimicrob Chemother. 1997 Jan; 39(1):1-3. PMID: 9044020.
    View in: PubMed
  83. Jacoby GA, Bush K. Amino acid sequences for TEM, SHV, and OXA extended-spectrum and inhibitor resistant beta-lactamases. 1997.
  84. Jacoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 1996 Apr; 34(4):908-11. PMID: 8815106; PMCID: PMC228915.
  85. Martínez-Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother. 1996 Feb; 40(2):342-8. PMID: 8834877; PMCID: PMC163113.
  86. Jacoby GA. Antimicrobial-resistant pathogens in the 1990s. Annu Rev Med. 1996; 47:169-79. PMID: 8712771.
    View in: PubMed
  87. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995 Jun; 39(6):1211-33. PMID: 7574506; PMCID: PMC162717.
  88. Jacoby GA. Urinary tract infection with Enterococcus faecalis. Ann Intern Med. 1995 Feb 01; 122(3):238. PMID: 7810949.
    View in: PubMed
  89. Jacoby GA. Extrachromosomal resistance in gram-negative organisms: the evolution of beta-lactamase. Trends Microbiol. 1994 Oct; 2(10):357-60. PMID: 7850201.
    View in: PubMed
  90. Jacoby GA. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis. 1994 Jun; 18(6):951-7. PMID: 8086559.
    View in: PubMed
  91. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol. 1994 Mar; 32(3):691-6. PMID: 8195380; PMCID: PMC263108.
  92. Jacoby GA. Genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 1994; 13 Suppl 1:S2-11. PMID: 7821301.
    View in: PubMed
  93. Rice LB, Marshall SH, Carias LL, Sutton L, Jacoby GA. Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes. Antimicrob Agents Chemother. 1993 Dec; 37(12):2760-1. PMID: 8109951; PMCID: PMC192806.
  94. Arstila T, Jacoby GA, Huovinen P. Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother. 1993 Dec; 32(6):809-16. PMID: 8144421.
    View in: PubMed
  95. Jacoby GA. Infectious complications in bone marrow transplantation. Resistant bacterial infections. Recent Results Cancer Res. 1993; 132:241-7. PMID: 8265866.
    View in: PubMed
  96. Katsanis G, Jacoby G. The frequency of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae. J Antimicrob Chemother. 1992 Mar; 29(3):345-6. PMID: 1592702.
    View in: PubMed
  97. Huovinen P, Jacoby GA. Sequence of the PSE-1 beta-lactamase gene. Antimicrob Agents Chemother. 1991 Nov; 35(11):2428-30. PMID: 1804019; PMCID: PMC245398.
  98. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Sep; 35(9):1697-704. PMID: 1952834; PMCID: PMC245253.
  99. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med. 1991 Feb 28; 324(9):601-12. PMID: 1992321.
    View in: PubMed
  100. Rice LB, Eliopoulos GM, Wennersten C, Goldmann D, Jacoby GA, Moellering RC. Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1991 Feb; 35(2):272-6. PMID: 1902647; PMCID: PMC244990.
  101. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Jan; 35(1):164-9. PMID: 1849707; PMCID: PMC244959.
  102. Jacoby GA, Blaser MJ, Santanam P, Hächler H, Kayser FH, Hare RS, Miller GH. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens. Antimicrob Agents Chemother. 1990 Dec; 34(12):2381-6. PMID: 1965106; PMCID: PMC172065.
  103. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC, Jacoby GA. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990 Nov; 34(11):2193-9. PMID: 2073110; PMCID: PMC172022.
  104. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1990 Nov; 34(11):2200-9. PMID: 1963529; PMCID: PMC172023.
  105. Jacoby GA, Carreras I. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 May; 34(5):858-62. PMID: 2193623; PMCID: PMC171706.
  106. Jacoby GA. Evolving beta-lactamases. Ayoub EM, Cassell GH, Branche WC Jr, Henry TJ, eds. Microbial determinants of virulence and host response. 1990; 361-76.
  107. Eliopoulos GM, Klimm K, Ferraro MJ, Jacoby GA, Moellering RC. Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). Diagn Microbiol Infect Dis. 1989 Nov-Dec; 12(6):481-8. PMID: 2560420.
    View in: PubMed
  108. Philippon A, Labia R, Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1989 Aug; 33(8):1131-6. PMID: 2679367; PMCID: PMC172613.
  109. Jacoby GA, Sutton L. Pseudomonas cepacia susceptibility to sulbactam. Antimicrob Agents Chemother. 1989 Apr; 33(4):583-4. PMID: 2729951; PMCID: PMC172485.
  110. Huovinen S, Huovinen P, Torniainen K, Jacoby GA. Evaluation of plasmid-encoded beta-lactamase resistance in Escherichia coli blood culture isolates. Eur J Clin Microbiol Infect Dis. 1988 Oct; 7(5):651-5. PMID: 3143575.
    View in: PubMed
  111. Jacoby GA, Medeiros AA, O'Brien TF, Pinto ME, Jiang H. Broad-spectrum, transmissible beta-lactamases. N Engl J Med. 1988 Sep 15; 319(11):723-4. PMID: 3261838.
    View in: PubMed
  112. Huovinen S, Huovinen P, Jacoby GA. Reliability of biotinylated DNA probes in colony hybridization: evaluation of an improved colony lysis method for detection of TEM-1 beta-lactamase. Mol Cell Probes. 1988 Mar; 2(1):83-5. PMID: 3260006.
    View in: PubMed
  113. Huovinen S, Huovinén P, Jacoby GA. Detection of plasmid-mediated beta-lactamases with DNA probes. Antimicrob Agents Chemother. 1988 Feb; 32(2):175-9. PMID: 3259120; PMCID: PMC172130.
  114. Levesque RC, Jacoby GA. Molecular structure and interrelationships of multiresistance beta-lactamase transposons. Plasmid. 1988 Jan; 19(1):21-9. PMID: 2840678.
    View in: PubMed
  115. Huovinen P, Huovinen S, Jacoby GA. Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother. 1988 Jan; 32(1):134-6. PMID: 3126705; PMCID: PMC172114.
  116. Yang Y, Jacoby GA, Livermore DM. LXA-1: a new plasmid-mediated beta-lactamase giving low-level resistance. FEMS Microbiol Lett. 1988; 52:97-102.
  117. Levesque RC, Medeiros AA, Jacoby GA. Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes. Mol Gen Genet. 1987 Feb; 206(2):252-8. PMID: 3035334.
    View in: PubMed
  118. Philippon AM, Paul GC, Jacoby GA. New plasmid-mediated oxacillin-hydrolyzing beta-lactamase in Pseudomonas aeruginosa. J Antimicrob Chemother. 1986 Apr; 17(4):415-22. PMID: 3086272.
    View in: PubMed
  119. Philippon AM, Paul GC, Thabaut AP, Jacoby GA. Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1986 Mar; 29(3):519-20. PMID: 3087285; PMCID: PMC180426.
  120. Medeiros AA, Levesque R, Jacoby GA. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother. 1986 Feb; 29(2):212-5. PMID: 3487284; PMCID: PMC176379.
  121. Jacoby GA. Resistance plasmids of Pseudomonas. Sokatch JR,ed. The Bacteria. The biology of Pseudomonas. 1986; X:265-93.
  122. Medeiros AA, Jacoby GA. Beta-lactamase-mediated resistance. Queener SW, Queener SF, Webber JA, eds. Beta-lactam antibiotics for clinical use. 1986; 49-84.
  123. Jacoby GA. Babesiosis. Gellis SS, Kagan BM, eds. Current pediatric therapy 12. 1986; 606.
  124. Jacoby GA, Sutton L. beta-Lactamases and beta-lactam resistance in Escherichia coli. Antimicrob Agents Chemother. 1985 Nov; 28(5):703-5. PMID: 3911882; PMCID: PMC176364.
  125. Medeiros AA, Cohenford M, Jacoby GA. Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother. 1985 May; 27(5):715-9. PMID: 3925874; PMCID: PMC180139.
  126. Hedges RW, Medeiros AA, Cohenford M, Jacoby GA. Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother. 1985 Apr; 27(4):479-84. PMID: 3890725; PMCID: PMC180078.
  127. Jacoby GA. Genetics and epidemiology of resistance. Greenwood D, O'Grady F, eds. The scientific basis of antimicrobial chemotherapy. 1985; 185-218.
  128. Jacoby GA. Strategies for dealing with antibiotic resistance. Sande MA, Root RK, eds. New dimensions in antimicrobial therapy. 1984; 83-100.
  129. Jacoby GA. Resistance plasmids of Pseudomonas aeruginosa. Bryan, LE, ed. Antimicrobial drug resistance. 1984; 497-514.
  130. Philippon AM, Paul GC, Jacoby GA. Properties of PSE-2 beta-lactamase and genetic basis for its production in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1983 Sep; 24(3):362-9. PMID: 6416161; PMCID: PMC185326.
  131. Jacoby GA, Sutton L, Knobel L, Mammen P. Properties of IncP-2 plasmids of Pseudomonas spp. Antimicrob Agents Chemother. 1983 Aug; 24(2):168-75. PMID: 6638986; PMCID: PMC185132.
  132. Simpson IN, Plested SJ, Budin-Jones MJ, Lees J, Hedges RW, Jacoby GA. Characterization of a novel plasmid-mediated beta-lactamase and its contribution to beta-lactam resistance in Pseudomonas aeruginosa. FEMS Microbiol Lett. 1983; 19:23-7.
  133. Jacoby GA, Sutton L. Restriction-modification systems determined by Pseudomonas plasmids. Plasmid. 1982 Sep; 8(2):141-7. PMID: 7178292.
    View in: PubMed
  134. Prince AS, Jacoby GA. Cloning the gentamicin resistance gene from a Pseudomonas aeruginosa plasmid in Escherichia coli enhances detection of aminoglycoside modification. Antimicrob Agents Chemother. 1982 Sep; 22(3):525-6. PMID: 6814358; PMCID: PMC183779.
  135. Falkiner FR, Jacoby GA, Keane CT, McCann SR. Amikacin, gentamicin and tobramycin resistant Pseudomonas aeruginosa in a leukaemic ward. Epidemiology and genetic studies. J Hosp Infect. 1982 Sep; 3(3):253-61. PMID: 6183318.
    View in: PubMed
  136. Richter JM, Jacoby GA, Schapiro H, Warshaw AL. Pancreatic abscess due to Candida albicans. Ann Intern Med. 1982 Aug; 97(2):221-2. PMID: 7049030.
    View in: PubMed
  137. Calderwood SB, Gardella A, Philippon AM, Jacoby GA, Moellering RC. Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982 Aug; 22(2):266-71. PMID: 6100423; PMCID: PMC183723.
  138. Medeiros AA, Hedges RW, Jacoby GA. Spread of a "Pseudomonas-specific" beta-lactamase to plasmids of enterobacteria. J Bacteriol. 1982 Feb; 149(2):700-7. PMID: 6276367; PMCID: PMC216562.
  139. Jacoby GA. Perils of prophylaxis. N Engl J Med. 1982 Jan 07; 306(1):43-4. PMID: 7053471.
    View in: PubMed
  140. Jacoby GA, Hunt JV, Kosinski KS, Demirjian ZN, Huggins C, Etkind P, Marcus LC, Spielman A. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med. 1980 Nov 06; 303(19):1098-100. PMID: 7191475.
    View in: PubMed
  141. Jacoby GA, Swartz MN. Plasmids: microbiological and clinical importance. Weinstein L, Fields BN, eds. Seminars in infectious disease. 1980; 3:1-37.
  142. Summers AO, Weiss RB, Jacoby GA. Transposition of mercury resistance from a transferable R plasmic of Escherichia coli. Plasmid. 1980 Jan; 3(1):35-47. PMID: 6278523.
    View in: PubMed
  143. Jacoby GA. Plasmid determined resistance to carbenicillin and gentamicin in Pseudomonas aeruginosa. Stuttard C, Rozee KR, eds. Plasmids and transposons: environmental effects and maintenance mechanisms. New York: Academic Press. 1980; 83-96.
  144. Jacoby GA, Sutton L, Medeiros AA. Plasmid-determined beta-lactamases of Pseudomonas aeruginosa. Nelson JD, Grassi C, eds. Current Chemotherapy and infectious disease. Washington DC: American Society for Microbiology. 1980; 769-71.
  145. Hedges RW, Jacoby GA. Compatibility and molecular properties of plasmid Rms 149 in Pseudomonas aeruginosa and Escherichia coli. Plasmid. 1980 Jan; 3(1):1-6. PMID: 6278522.
    View in: PubMed
  146. Jacoby GA, Low KB. Genetics of antimicrobial resistance. The effects on human health of subtherapeutic use of antimicrobials in animal feeds. 1980; 92-129.
  147. Jacoby GA, Sutton L. Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different beta-lactamases. Antimicrob Agents Chemother. 1979 Aug; 16(2):243-5. PMID: 114107; PMCID: PMC352832.
  148. Jacoby GA. Plasmids of Pseudomonas aeruginosa. Doggett RD, ed. Pseudomonas aeruginosa: clinical manifestations of infection and current therapy. 1979; 271-309.
  149. Jacoby GA, Matthew M. The distribution of beta-lactamase genes on plasmids found in Pseudomonas. Plasmid. 1979 Jan; 2(1):41-7. PMID: 112600.
    View in: PubMed
  150. Jacoby GA, Weiss R, Korfhagen TR, Krishnapillai V, Jacob AE, Hedges RW. An explanation for the apparent host specificity of Pseudomonas plasmid R91 expression. J Bacteriol. 1978 Dec; 136(3):1159-64. PMID: 102634; PMCID: PMC218551.
  151. Jacoby GA, Rogers JE, Jacob AE, Hedges RW. Transposition of Pseudomonas toluene-degrading genes and expression in Escherichia coli. Nature. 1978 Jul 13; 274(5667):179-80. PMID: 96356.
    View in: PubMed
  152. Sutton L, Jacoby GA. Plasmid-determined resistance to hexachlorophene in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Apr; 13(4):634-6. PMID: 96729; PMCID: PMC352301.
  153. Summers AO, Jacoby GA. Plasmid-determined resistance to boron and chromium compounds in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Apr; 13(4):637-40. PMID: 96730; PMCID: PMC352302.
  154. Korfhagen TR, Sutton L, Jacoby GA. Classification and physical properties of Pseudomonas plasmids. Schlessinger D, ed. Microbiology-1978. Washington, DC: American Socieity for Microbiology. 1978; 221-4.
  155. Summers AO, Jacoby GA, Swartz MN, McHugh G, Sutton L. Metal cation and oxyanion resistance in plasmids of gram-negative bacteria. Schlessinger D, ed. Microbiology-1978. Washington DC: American Society for Microbiology. 1978; 128-31.
  156. Jacoby GA, Sutton L. Restriction and modification determined by a Pseudomonas R plasmid. Plasmid. 1977 Nov; 1(1):115-6. PMID: 108695.
    View in: PubMed
  157. Falkiner FR, Keane CT, Dalton M, Clancy MT, Jacoby GA. Cross infection in a surgical ward caused by Pseudomonas aeruginosa with transferable resistance to gentamicin and tobramycin. J Clin Pathol. 1977 Aug; 30(8):731-7. PMID: 413842; PMCID: PMC476536.
  158. Jacoby GA. Classification of plasmids in Pseudomonas aeruginosa. Schlessinger D, ed. Microbiology-1977. Washington DC: American Society for Microbiology. 1977; 119-26.
  159. Jacoby GA, Shapiro JA. Plasmids studied in Pseudomonas aeruginosa and other pseudomonads. Bukhari AI, Shapiro J, Adhya S, eds. DNA insertion elements, plasmids, and episomes. 1977.
  160. Summers AO, Jacoby GA. Plasmid-determined resistance to tellurium compounds. J Bacteriol. 1977 Jan; 129(1):276-81. PMID: 401494; PMCID: PMC234924.
  161. Lehrbach P, Kung AH, Lee BT, Jacoby GA. Plasmid modification of radiation and chemical-mutagen sensitivity in Pseudomonas aeruginosa. J Gen Microbiol. 1977 Jan; 98(1):167-76. PMID: 188973.
    View in: PubMed
  162. Jacoby GA, Jacob AE. Recombination between Pseudomonas aeruginosa plasmids of incompatibility groups P-1 and P-2. Bukhari AI, Shapiro J, Adhya S, eds. DNA insertion eleements, plasmids, and episomes. Cold Spring Harbor: Cold Spring Harbor Laboratories. 1977; 147-50.
  163. Jacoby GA, Jacob AE, Hedges RW. Recombination between plasmids of incompatibility groups P-1 and P-2. J Bacteriol. 1976 Sep; 127(3):1278-85. PMID: 821925; PMCID: PMC232921.
  164. Jacoby GA. R plasmids determining gentamicin or tobramycin resistance in Pseudomonas aeruginosa. Mitsuhashi S, Rosival L, Krcmery V, eds. Drug-inactivating enzymes and antibiotic resistance. Berlin: Springer-Verlag. 1975; 287-95.
  165. Jacoby GA. Propertries of R plasmids in Pseudomonas aeruginosa. Schlessinger D., ed. Microbiology-1974. Washington DC: American Society for Microbiology. 1975; 36-42.
  166. Jacoby GA. Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance. Antimicrob Agents Chemother. 1974 Dec; 6(6):807-10. PMID: 4217586; PMCID: PMC444740.
  167. Jacoby GA. Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974 Sep; 6(3):239-52. PMID: 15830469; PMCID: PMC444633.
  168. Jacoby GA, Swartz MN. Psittacosis. Conn HF, Conn RB Jr, eds. Current diagnosis 4. 1974; 110-11.
  169. Jacoby GA, Swartz MN. Fever of undetermined origin. N Engl J Med. 1973 Dec 27; 289(26):1407-10. PMID: 4585101.
    View in: PubMed
  170. Jacoby GA. An R factor defects to our side. N Engl J Med. 1972 Mar 16; 286(11):602-3. PMID: 4550892.
    View in: PubMed
  171. Jacoby GA. Control of the argECBH cluster in Escherichia coli. Mol Gen Genet. 1972; 117(4):337-48. PMID: 4560774.
    View in: PubMed
  172. Jacoby GA. Mapping the gene determining ornithine transcarbamylase and its operator in Escherichia coli B. J Bacteriol. 1971 Nov; 108(2):645-51. PMID: 4942757; PMCID: PMC247122.
  173. Jacoby GA. Carbenicillin and gentamicin. N Engl J Med. 1971 May 13; 284(19):1096-8. PMID: 5205659.
    View in: PubMed
  174. Jacoby GA, Gorini L. A unitary account of the repression mechanism of arginine biosynthesis in Escherichia coli. I. The genetic evidence. J Mol Biol. 1969 Jan 14; 39(1):73-87. PMID: 4938817.
    View in: PubMed
  175. Jacoby GA, Gorini L. The effect of streptomycin and other aminoglycoside antibiotics on protein synthesis. Gottlieb D, Shaw PD, eds. Antibiotics I, Mechanism of action. 1967; 726-47.
  176. Gorini L, Jacoby GA, Breckenridge L. Ribosomal ambiguity. Cold Spring Harb Symp Quant Biol. 1966; 31:657-64. PMID: 4866410.
    View in: PubMed
    View in: PubMed
  179. Jacoby GA. The induction and repression of amino acid oxidation in Pseudomonas fluorescens. Biochem J. 1964 Jul; 92(1):1-8. PMID: 4378798; PMCID: PMC1215429.
    View in: PubMed
    View in: PubMed
    View in: PubMed
  183. ZANNONI VG, JACOBY GA, MALAWISTA SE, LA DU BN. The effect of folic acid on tyrosine metabolism in guinea pigs. J Biol Chem. 1962 Nov; 237:3506-9. PMID: 14003223.
    View in: PubMed
  184. JACOBY GA, LA DU BN. Nonspecificity of tyrosine transaminase: an explanation for the simultaneous induction of tyrosine, phenylalanine, and tryptophan transaminase activities in rat liver. Biochem Biophys Res Commun. 1962 Aug 07; 8:352-6. PMID: 14450759.
    View in: PubMed
  185. LA DU BN, HOWELL RR, JACOBY GA, SEEGMILLER JE, ZANNONI VG. The enzymatic defect in histidinemia. Biochem Biophys Res Commun. 1962 May 11; 7:398-402. PMID: 14461183.
    View in: PubMed
  186. ZANNONI VG, JACOBY GA, LA DU BN. The effect of coenzyme Q-10 on tyrosine metabolism in guinea pigs. Biochem Biophys Res Commun. 1962 Apr 20; 7:220-4. PMID: 14009821.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at For faculty personal and demographic information, contact HMS Office for Faculty Affairs at
Jacoby's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (437)
Co-Authors (8)
Similar People (60)
Same Department 
Physical Neighbors
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.